Strides Pharma Science announced that the Board of Directors of the Company at its meeting held on 10 May 2019, has recommended a Final dividend of Rs.3 per share (i.e.30%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Strides Pharma Science declined 91.65% to Rs 47.51 crore in the quarter ended March 2019 as against Rs 568.84 crore during the previous quarter ended March 2018. Sales rose 25.35% to Rs 839.70 crore in the quarter ended March 2019 as against Rs 669.89 crore during the previous quarter ended March 2018.

For the full year,net profit declined 51.15% to Rs 324.61 crore in the year ended March 2019 as against Rs 664.52 crore during the previous year ended March 2018. Sales rose 5.85% to Rs 3011.68 crore in the year ended March 2019 as against Rs 2845.12 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

Net profit of Strides Pharma Science declined 87.01% to Rs 98.82 crore in the quarter ended March 2019 as against Rs 760.54 crore during the previous quarter ended March 2018. Sales rose 11.71% to Rs 434.56 crore in the quarter ended March 2019 as against Rs 389.02 crore during the previous quarter ended March 2018.

For the full year,net profit declined 87.62% to Rs 110.37 crore in the year ended March 2019 as against Rs 891.60 crore during the previous year ended March 2018. Sales rose 4.62% to Rs 1537.44 crore in the year ended March 2019 as against Rs 1469.61 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

Strides Pharma Science announced that the Board of Directors of the Company at its meeting held on 10 May 2019, has recommended a Final dividend of Rs.3 per share (i.e.30%), subject to the approval of the shareholders.

Powered by Capital Market - Live News